COHANCE LIFESCIENCES
Back to Cashflow Statement
|
COHANCE LIFESCIENCES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹36 Cr | ₹-18 Cr | ₹20 Cr | ₹37 Cr | ₹-4.51 Cr |
What is the latest Net Cash Inflow / Outflow ratio of COHANCE LIFESCIENCES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹-18 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹37 Cr |
| Mar2021 | ₹-4.51 Cr |
How is Net Cash Inflow / Outflow of COHANCE LIFESCIENCES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | Positive | |
| Mar2024 | ₹-18 Cr | Negative | |
| Mar2023 | ₹20 Cr | -45.86 | |
| Mar2022 | ₹37 Cr | Positive | |
| Mar2021 | ₹-4.51 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹16,268.2 Cr | -1.5% | -6.1% | -57.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | -1.5% |
-6.1% |
-57.4% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses